|
Positively Positive - Living with HIV/AIDS:
HIV/AIDS News Archive - February 2022
Three-time UM alum targets HIV/STI research in Manitoba and globally
FEBRUARY 28, 2022 - While borders have largely closed due to COVID-19, Dr. Leigh McClarty has been finishing her post-doctorate in global public health. While normally the researcher would be travelling around the world to better understand health care in different countries, she has continued to look for ways to improve health care for people with HIV and other STIs here in Manitoba.
Caring Cross Presents Research Involving Anti-HIV DuoCAR-T Cell Therapy at the Conference on Retroviruses and Opportunistic Infections (CROI) 2022
GAITHERSBURG, Md., Feb. 28, 2022 /PRNewswire/ -- Caring Cross, a 501(c)(3) non-profit dedicated to accelerating the development of advanced medicines and enabling access to cures for all patients, everywhere, announced that Kim Anthony-Gonda, Ph.D., Director of Infectious Diseases at Caring Cross, presented a poster highlighting the organization's Anti-HIV DuoCAR-T Cell Therapy at the Conference on Retroviruses and Opportunistic Infections (CROI) 2022.
Suspending syringe services programs will result in an increase of HIV infections, study finds
PROVIDENCE, R.I. [Brown University] - February 28, 2022 - Using a simulation modeling approach, Brown researchers estimate that closing syringe services programs, even for one year, will cause cases of HIV to rise.
Syringe services programs — sites where people who use drugs can access sterile syringes and dispose of injection equipment — often face political backlash. But a new study shows the effectiveness of these programs in both curbing HIV transmission among people who use drugs and preventing future outbreaks.
Read more...
New tool launched to help provide person-centred care for people living with HIV
28 February 2022 - The POSITIVE Outcomes tool can support people with HIV and help healthcare professionals understand where to focus their care.
Researchers from King’s College London and the British HIV Association (BHIVA), with input from HIV community members of the UK Community Advisory Board (UK-CAB), have launched a tool to support people with HIV and help healthcare professionals understand where to focus their care.
National AIDS Memorial Honors the Legacy of Pedro Zamora on his 50th Birthday by Announcing Eleven Scholars who are Carrying his Torch Forward
SAN FRANCISCO, Feb. 28, 2022 /PRNewswire/ -- - Pedro Zamora Young Leaders Scholarship provides financial support for the academic aspirations of young activists working to advance health and social justice in their communities
- Through the support of Gilead Sciences and other partners, the program has provided more than $410,000 in scholarships to 112 students since 2009
The National AIDS Memorial marks Black History Month and National Black HIV/AIDS Awareness Day with featured online programming honoring Black lives touched by AIDS. A specially curated selection of stories is being featured as part of a virtual exhibition of the AIDS Memorial Quilt and engraved names in the National AIDS Memorial Grove.
HIV IS NOT A CRIME AWARENESS DAY OBSERVED ON FEBRUARY 28TH
LOS ANGELES, Feb. 28, 2022 /PRNewswire/ -- The Elizabeth Taylor AIDS Foundation (ETAF) and The Sero Project announce today as the first official HIV IS NOT A CRIME Awareness Day. The date is significant as it ties a symbolic bow to the closing of National Black History Month and the beginning of National Women's History Month - two demographics that are disproportionately impacted by both the HIV epidemic & HIV criminalization. This date is also a symbolic nod to the legacy of ETAF Founder, Elizabeth Taylor following the day of what would be her 90th birthday. Elizabeth held a tireless commitment to raising awareness and fighting the stigma of HIV and AIDS globally.
D.C.’s HIV+ population is aging. Doctors say that’s a good sign.
February 28, 2022 -
Chelsea Cirruzzo - More than half of people in D.C. living with HIV are 50 years and older, which is a positive sign, according to the health care providers who treat them.
Why it matters: D.C. has aggressive goals to slash new HIV transmissions and ensure that 95% of Washingtonians with HIV know their status, are in treatment, and have reached viral suppression by 2030.
Read more...
Many Americans still paying high costs months after insurers were ordered to cover HIV preventive care
February 28, 2022 - By Sarah Varney and Kaiser Health News - Anthony Cantu, 31, counsels patients at a San Antonio health clinic about a daily pill shown to prevent HIV infection. Last summer, he started taking the medication himself, an approach called preexposure prophylaxis, better known as PrEP. The regimen requires laboratory tests every three months to ensure the powerful drug does not harm his kidneys and that he remains HIV-free.
Read more...
Philly AIDS Thrift awards over $300k in grants for HIV prevention, support
PHILADELPHIA - FEBRUARY 26, 2022 - By Michele Zipkin - Philly AIDS Thrift (PAT) and Philly AIDS Thrift at Giovanni’s Room recently awarded $300,035 in grants to 27 Delaware Valley organizations and initiatives that provide HIV prevention, care and support. To date, PAT leadership has awarded $3.6 million in donations to community organizations.
Read more...
CROI 2022
25 February 2022 - The Conference on Retroviruses and Opportunistic Infections (CROI) took place from 12 to 16 February. CROI 2022 was held virtually this year due to coronavirus.
Read more...
Age-Related Comorbidities and Quality-of-Life Issues in Patients Living With HIV
February 25, 2022 - Gina Battaglia, PhD - For people living with HIV, age-related comorbidities, such as obesity and diabetes, as well as quality-of-life issues remain challenges. Our Peer Exchange panel discusses clinical approaches for this patient population and trying to keep them in good health.
Read more...
Cicilline, Lee, Eshoo, Maloney Lead Colleagues in Urging FDA to End Homophobic Blood Donation Deferral Period
Feb 25, 2022 - Congressman David Cicilline - This week, Representatives David N. Cicilline (RI-01), Barbara Lee (CA-13), Anna G. Eshoo (CA-18), and Sean Patrick Maloney (NY-18) were joined by 142 of their colleagues in urging the Food and Drug Administration (FDA) to end the blanket three-month blood donation deferral period for men who have sex with men (MSM) and transition to an individual risk assessment to determine donor eligibility.
UNAIDS urges protection and continuity of health and HIV services for people living with and affected by HIV in Ukraine
GENEVA, 25 February 2022 - Amidst the ongoing military offensive against Ukraine, UNAIDS is calling for the protection of health workers and uninterrupted continuation of HIV and health services for all people, including people living with and affected by HIV. Ukraine has the second largest AIDS epidemic in the region. It is estimated that there are 250 000 people living with HIV in Ukraine, 156 000 of whom are on antiretroviral therapy, medication that needs to be taken daily for people to remain alive and well.
The Lancet Child & Adolescent Health: At least 5 million children have lost a parent or caregiver due to COVID-19 since March 2020, updated figures suggest
24-FEB-2022 - THE LANCET - The number of children estimated to have experienced the death of a parent or caregiver as a result of the COVID-19 pandemic has surged to more than 5.2 million globally, according to a new modelling study published in The Lancet Child & Adolescent Health journal.
Only 30 babies out of 1,665 births from HIV-positive mothers tested positive for infection in last 5 years: MDACS
February 24, 2022 - by Rupsa Chakraborty - Data from Mumbai District AIDS Control Society (MDACS) showed that per 56 deliveries of HIV infected mothers, only one newborn got the infection.
The number of mother-to-child transmitted HIV infections from an HIV-positive woman to her child during pregnancy, childbirth and breastfeeding has dropped drastically in Mumbai with only 30 babies testing positive for HIV infection in the last five years out of 1,665 deliveries of infected mothers.
Read more...
CAPITO, MANCHIN ANNOUNCE MORE THAN $1.2 MILLION FOR HIV/AIDS PREVENTION, TREATMENT IN WEST VIRGINIA
FEBRUARY 24, 2022 - Senator Shelley Capito - U.S. Senators Shelley Moore Capito (R-W.Va.) and Joe Manchin (D-W.Va.), members of the Senate Appropriations Committee, today announced $1,284,922 from the U.S. Department of Health and Human Services (HHS) for critical HIV/AIDS prevention and treatment in West Virginia.
First Clinical Trial of CRISPR-Based HIV Therapy Founded on Breakthrough Research at Lewis Katz School of Medicine at Temple University
(Philadelphia, PA) - February 24 2022 - The first clinical trial of a gene-editing therapy for human immunodeficiency virus type 1 (HIV) infection is now underway, thanks to a major collaborative effort between scientists at the Lewis Katz School of Medicine at Temple University and investigators at Excision BioTherapeutics, Inc. The trial, designed to evaluate the safety, tolerability, and efficacy of EBT-101, a unique gene-editing treatment that could alter the future of HIV therapeutics, marks a major step forward in the effort to find a cure for HIV/AIDS.
Dallas gay rights and AIDS services advocate Don Maison dead at 74
February 23, 2022 - by Rich Barlow - As a civil rights lawyer and former head of AIDS Services of Dallas, Don Maison fought for the rights of LGBTQ Texans and those living with HIV and AIDS. He was a pillar in the housing advocacy and gay rights world.
Don Maison, a gay rights leader and longtime leader of AIDS Services of Dallas, died Monday after being diagnosed in November with esophageal cancer. He was 74.
Read more...
Is It Time for Free HIV Self-Tests From the Government?
24 February 2022 - By Heather Boerner - A program that mailed free HIV tests to 100,000 Americans did a better job of reaching people who’d never been tested.
Give the people what they want. According to data presented at the Conference on Retroviruses and Opportunistic Infections 2022 (CROI 2022), when it comes to HIV testing, what people want is to perform those tests at home—and to get them for free.
Read more...
Ageing with HIV
February 24, 2022 - Advances in antiretroviral therapy mean more people are living – and ageing – with HIV. However, challenges exist, from the biological interplay of HIV and ageing, to the impacts of stigma, and delayed presentation for care on health-related quality of life for older people with HIV. This Series aims to explore these issues and how healthcare systems can adapt to the evolving needs of people ageing with HIV.
Read more...
Five African Presidents Launch Global Fund's US$18 Billion Campaign to Restore Progress Against AIDS, TB and Malaria Amid COVID-19 Disruption
GENEVA - 23 February 2022 - Presidents of DRC, Kenya, Rwanda, Senegal and South Africa join global leaders, communities, civil society organizations and private sector partners to kick off the Global Fund’s Seventh Replenishment campaign.
US$18 billion would save 20 million lives, cut HIV, TB and malaria deaths by 65% and strengthen health systems to reinforce pandemic preparedness.
The Global Fund to Fight AIDS, Tuberculosis and Malaria and the presidents of the Democratic Republic of the Congo, the Republic of Kenya, the Republic of Rwanda, the Republic of Senegal, and the Republic of South Africa launched the Global Fund’s Seventh Replenishment campaign today at a global health summit held virtually.
PIONEERING SIMULATIONS FOCUS ON HIV-1 VIRUS
February 23, 2022 by Jorge Salazar - First computer models developed for deadly virus's envelope and genome capsid
When is a container not just a container?
For the HIV-1 virus, a double layer of fatty molecules called lipids not only serves as its container, but also plays a key role in the virus's replication and infectivity. Scientists have used supercomputers to complete the first-ever biologically authentic computer model of the HIV-1 virus liposome, its complete spherical lipid bilayer.
AP Was There: Magic announces he has HIV, retires from NBA
INGLEWOOD, Calif. - February 23, 2022 - John Nadel - Magic Johnson stunned the NBA and those watching his news conference live on TV in 1991 by announcing he had tested positive for HIV and would be retiring from the Los Angeles Lakers. Johnson and the Lakers’ physician both made clear the guard didn’t have AIDS. Johnson said he didn’t know how he contracted the virus. Johnson later returned to play 36 games in 1996, including the playoffs, before retiring again. The Associated Press is republishing verbatim the story on Johnson’s announcement Nov. 7, 1991:
Read more...
HIV confidentiality laws by state: What to know
February 23, 2022 - by Jon Johnson - HIV is a virus that attacks the immune system. The virus can transmit from person to person through contact with infected bodily fluids, such as blood, semen, or vaginal fluids. If left untreated, HIV can progress to AIDS.
This article discusses the different types of laws relating to HIV in the U.S. and outlines the many state-specific laws surrounding the virus.
Read more...
From HIV/AIDS to COVID, New Minor Probes Religion in Science and Medicine
February 23, 2022 - by Rich Barlow - CAS courses, aimed especially at pre-health students, show how people mix the sacred and science
How religion inflects science is enduring and important enough that the College of Arts & Sciences religion department has a new minor, titled, aptly, Religion in Science and Medicine. One course revisits the contentious morality debate surrounding the HIV/AIDS epidemic in the 1980s and ’90s.
Read more...
FDA Permits Marketing of First Condom Specifically Indicated for Anal Intercourse
February 23, 2022 - Other FDA-Cleared Condoms Can Continue to Be Used for Contraception and to Prevent STIs
Today, the U.S. Food and Drug Administration authorized the marketing of the first condoms specifically indicated to help reduce transmission of sexually transmitted infections (STIs) during anal intercourse. The condoms, which will be marketed as the One Male Condom, are also indicated as a contraceptive to help reduce the risk of pregnancy and the transmission of STIs during vaginal intercourse.
CURE HEADLINES FROM CROI 2022
Feb 22, 2022 - defeatHIV - Recording of a community meeting to discuss the latest cure-related news from CROI 2022.
Have HIV-associated neurological disorders declined in people with HIV due to recent antiretrovirals?
22 February 2022 - Alain Volny-Anne - The prevalence of HIV-associated neurocognitive disorder (HAND) has decreased over the last decade among people with HIV who take antiretroviral therapy, according to an Italian study presented last week at the Conference on Retroviruses and Opportunistic Infections (CROI 2022). Lower rates of HAND were associated with various patient characteristics and HIV-related factors, including the use of dual therapies and integrase inhibitor-based regimens.
Read more...
AHF Mourns Dr. Paul Farmer, Global AIDS Treatment Champion
WASHINGTON (February 21, 2022) - by Ged Kenslea - Global nonprofit AIDS care provider salutes co-founder of Partners in Health for his tireless work helping people living with HIV around the world access lifesaving antiretroviral medications
AIDS Healthcare Foundation (AHF) mourns the death of Dr. Paul Farmer, a global exemplar helping people in poor countries access lifesaving AIDS treatment long before many in the field thought it practical or possible. Farmer, 62, was co-founder of Partners in Health, a 35-year-old global nonprofit organization delivering health care to the world’s poorest places and partnering with local governments to bring about global change. He died in his sleep in Rwanda early Monday, according to multiple news sources.
AIDS, Catholics, and the untold stories of compassion in the face of fear
2022-02-21 - Set against the backdrop of the HIV and AIDS epidemic of the late 20th century and the Catholic Church's crackdown on gay and lesbian activists, journalist Michael O'Loughlin’s book, "Hidden Mercy," (Broadleaf Books) searches out the untold stories of those who didn't look away, who at great personal cost chose compassion.
LISTEN...
Impoverished couple living with HIV pleads for food
2022-02-21 - by Charlotte Nambadja - AN HIV-positive couple from the Babylon informal settlement at Katutura is pleading good Samaritans to come to their rescue with food and decent accommodation.
Belinda Mukumelo (53) and Moses Uirab (53) have been HIV-positive for the past eight years.
The two live in a dilapidated shack, and say they can barely afford one meal per day to feed themselves and their three children.
Read more...
Global health champion Dr. Paul Farmer has died
February 21, 2022 - MALAKA GHARIB - Dr. Paul Farmer, global health champion, Harvard Medical School professor, anthropologist and co-founder of the nonprofit health organization Partners in Health, has died at age 62.
Read more...
Is Failing to Disclose HIV/AIDS Status Before Sexual Intercourse a Criminal Offence?
21/02/2022 - BY SONIA HICKEY - A Sydney man has been found not guilty after being charged with failing to disclose his positive HIV status to a woman he had sexual intercourse with.
NSW Local Court magistrate Sharon Holdsworth heard the case in a closed courtroom, ultimately finding the man not guilty and dismissing the charge.
Read more...
CBO Unveils A Programme To Fight Stigma On People Living With HIV
February 20, 2022 - In a bid to end the stigma on people living with HIV in Tana River, a Community-Based Organization (CBO) has started an awareness campaign.
Kipini Integrated Community Enterprise (KICE) Programme Officer, Jamila Yusuf, said several people living with HIV are facing stigma from people around them thus it is a herculean task for them to seek medication.
Read more...
CROI 2022: Professor Joel Palefsky talks about anal cancer
Feb 18, 2022 -NAM - aidsmap - Professor Joel Palefsky from the University of California San Francisco talks about the ANCHOR trial, which has showed that screening and early treatment reduces anal cancer in people with HIV.
Experts at UC San Diego Health Offer Insights on Latest HIV Breakthrough
18-Feb-2022 - Thanks to a transplant of umbilical cord blood from an AIDS-resistant donor, a woman of mixed race appears to have become just the third person to be cured of HIV. As reported this week in the New York Times, the middle-aged woman with HIV received cord blood from an AIDS-resistant donor to treat myeloid leukemia. Fourteen months later, it was discovered that she was free of the virus and did not require antiretroviral therapy. Cord blood is more widely available than the adult stem cells used in bone marrow transplants linking to the recoveries of two previous male HIV patients, and it does not need to be as closely matched to recipients. Since most cord blood donors are of Caucasian origin, a partial match has the potential to cure more Americans of racially diverse backgrounds who have both HIV and cancer each year. The following UC San Diego Health experts are available to answer questions:
Patient Possibly Cured of HIV Infection by Special Stem-Cell Transplant
FEBRUARY 18, 2022 - A patient living with HIV who received a blood stem cell transplant for high-risk acute myeloid leukemia has been free of the virus for 14 months after stopping HIV antiretroviral drug treatment, suggesting a cure, according to the Weill Cornell Medicine physician-scientists who performed the transplant and managed her care. As in two other successful cases that have been reported, the transplanted donor cells bore a mutation that makes them resistant to HIV infection.
The new case of long-term HIV remission was reported on Feb. 15 at the 29th annual Conference on Retroviruses and Opportunistic Infections, in Denver.
World still decades away from a viable HIV cure, despite milestone development
18 February 2022 - By Harriet Barber - The ultimate goal of having one vaccine and being cured is still a long way off, leading scientist warns
The world is still 10 to 20 years away from a viable HIV cure, despite a milestone development this week, scientists have warned.
Prof Sharon Lewin, president-elect of the International AIDS Society, told The Telegraph that although the news this week that a woman was cured of the disease is an “exciting find”, the world is still at least a decade away from a widespread cure.
Read more...
NASTAD, AIDS United award $7.5 million to syringe services programs to expand capacity to respond to COVID-19
February 18, 2022 - WASHINGTON - NASTAD and AIDS United announced Friday the Tier One awardees of a new grants program, Expanding Syringe Services Programs Capacity to Respond to COVID-19. This unique funding opportunity awarded $7.5 million to syringe services programs across three tiers of the project to assist in their COVID-19 pandemic response. Friday’s announcement was for tier one of the project, a total of $5 million in grants. The initiative is supported by a cooperative agreement from the collaborative centers within the Centers for Disease Control and Prevention.
Hepatitis C Patients Cured with Antiviral Medicines are Less Likely to be Hospitalized, Need ER Care for Liver, Other Health-Related Issues
Newswise — DETROIT (February 18, 2022) - Henry Ford Health System-led study underscores the powerful effect of direct-acting antivirals on patient’s overall health.
Researchers at Henry Ford Health System, as part of a national hepatitis C collaborative, report that patients with chronic hepatitis C who are treated with direct-acting antiviral medicines are less likely to be hospitalized or seek emergency care for liver and non-liver related health issues.
The study, published online in Clinical Infectious Diseases, underscores the extraordinary effect of these newer antivirals, which have been shown to cure hepatitis C in 98 percent of patients who take them. Patients are said to be cured when the virus is no longer detectable in their blood.
CROI 2022: Professor Yvonne Bryson talks about HIV remission after a stem cell transplant
Feb. 17, 2022 - NAM - aidsmap - At CROI 2022, Professor Yvonne Bryson from the University of California Los Angeles talks about the woman in New York who has no detectable HIV 14 months after stopping antiretroviral therapy following a stem-cell transplant for leukaemia.
CROI 2022: Dr Roger Shapiro talks about antibody treatment for children
Feb. 17, 2022 - NAM - aidsmap - Dr Roger Shapiro from Harvard University talks about antibody treatment for children with HIV at CROI 2022.
NIH’s Dr. Carl Dieffenbach Discusses Highlights of HIV Cure, Treatment and Prevention Research from CROI 2022
February 17, 2022 - By: HIV.gov - In an HIV.gov video conversation yesterday, NIH’s Dr. Carl Dieffenbach discussed some of the pivotal HIV research advances presented this week at the 2022 virtual Conference on Retroviruses and Opportunistic Infections (CROI 2022). Dr. Dieffenbach, Director of the Division of AIDS at NIH’s National Institute of Allergy and Infectious Diseases (NIAID), covered developments in HIV cure research, HIV treatment and HIV prevention. Watch the conversation with Dr. Dieffenbach:
Testing uncovers high prevalence of active syphilis among people with HIV
17 February 2022 - Liz Highleyman - Screening for precancerous anal cell changes and treating them early lowers the risk of progression to anal cancer in people living with HIV, according to results from the ANCHOR study presented this week at the Conference on Retroviruses and Opportunistic Infections (CROI 2022).
Read more...
Screening and early treatment reduce anal cancer risk by 57% in people living with HIV
17 February 2022 - Liz Highleyman - Screening for precancerous anal cell changes and treating them early lowers the risk of progression to anal cancer in people living with HIV, according to results from the ANCHOR study presented this week at the Conference on Retroviruses and Opportunistic Infections (CROI 2022).
Read more...
The Berlin Patient
16 February 2022 - Timothy Ray Brown was the first person in the world to be cured of HIV/AIDS. In the 1990s, he received a cutting-edge treatment that combined cancer and HIV therapy.
Possible third cure to HIV: progress in a time of regression
CHICAGO - February 16, 2022 - In the time of COVID-19, ‘any positive news about how we can better attack HIV is welcome right now,’ says Northwestern Medicine expert Richard D’Aquila
Following the news that a third person has been cured of HIV, a Northwestern Medicine expert says using partially matched blood cells could be used to cure many people living with both cancer and HIV, though he said this treatment is not likely to be offered to people without life-threatening cancer.
The novel treatment, which uses blood from umbilical cords, may have less complications than past cures and open doors for patients of more diverse backgrounds to receive the treatment.
Free HIV self-test kits now available to the public across Saskatchewan
Feb 16, 2022 - Laura Sciarpelletti - The antibody test is 99.5% accurate
Saskatchewan residents are now able to test themselves for the human immunodeficiency virus (HIV) at home.
Free HIV self-test kits are available to the general public at 23 locations across the province. The province said test kits can also be purchased online and delivered directly from the manufacturer to a Saskatchewan resident's home.
Read more...
Unexpected findings detailed in new portrait of HIV
February 16, 2022 - Jake Ellison - Using powerful tools and techniques developed in the field of structural biology, researchers at the University of Washington and Scripps Research have discovered new details about the human immunodeficiency virus, HIV. The findings bring into focus the basic architecture of the virus just above and below its surface and may help in the design and development of a vaccine that can protect against AIDS.
New Clinical Data Support the Sustained Efficacy of Long-acting Lenacapavir, Gilead’s Investigational HIV-1 Capsid Inhibitor
February 16, 2022 - FOSTER CITY, Calif.-- (BUSINESS WIRE) -- – One-Year Data From the CAPELLA and CALIBRATE Trials Show Lenacapavir Leads to High Rates of Virologic Suppression in Heavily Treatment-Experienced People Living with Multi-Drug Resistant HIV and Treatment-Naïve People Living with HIV –
Gilead Sciences, Inc. (Nasdaq: GILD) today announced new one-year results from the ongoing Phase 2/3 CAPELLA trial evaluating lenacapavir, the company’s investigational, long-acting HIV-1 capsid inhibitor, in heavily treatment-experienced people living with multi-drug resistant HIV. The findings demonstrated that lenacapavir, administered subcutaneously every six months in combination with other antiretrovirals, achieved high rates of virologic suppression and clinically meaningful increases in CD4 counts in people living with HIV whose virus was no longer effectively responding to their current therapy. In this patient population with high unmet medical need, 83% (n=30/36) of participants receiving lenacapavir in combination with an optimized background regimen achieved an undetectable viral load (50 copies/mL) at Week 52. The data were presented at the 29th Conference on Retroviruses and Opportunistic Infections (virtual CROI 2022).
Study suggests young women prefer vaginal ring over oral PrEP for HIV prevention
15 February 2022 - By Caitlyn Stulpin - Adolescent girls and young women preferred the dapivirine ring over oral PrEP for HIV prevention by a two to one margin in a study conducted in three African countries, researchers reported Tuesday.
Read more...
UCLA Health at CROI: Presenting the case of a woman with HIV-1 in remission following specialized stem cell transplantation for leukemia
February 15, 2022 - UCLA researchers presented today the first case of a U.S. woman living with HIV-1 that is in remission after she received a new combination of specialized stem cell transplants for treatment of acute myeloid leukemia (AML). The oral abstract was presented at CROI 2022, the Conference on Retroviruses and Opportunistic Infections.
First Kenyan to publicly declare he was HIV+ lived for 35 years with virus
15 February 2022 - by GORDON OSEN AND MAGDALINE SAYA - Joe Muriuki was the first known to come out and declare he was HIV+, shocking many Kenyans
Joe Muriuki, an Aids hero, is dead. He was age 62.
He was the first known Kenyan to step forward, endure heartless stigma and declare he had he was HIV positive.
Read more...
Heart attack rates are declining, but not in people with HIV
15 February 2022 - Liz Highleyman - People living with HIV in two US cities had a 60% higher risk of myocardial infarction, or heart attack, compared with HIV-negative individuals, with a widening disparity over time, according to research presented yesterday at the Conference on Retroviruses and Opportunistic Infections (CROI 2022). These findings underscore the need for ongoing monitoring and interventions to manage cardiovascular disease in this population.
Read more...
Researchers document third known case of HIV remission involving stem cell transplant
February 15, 2022 - Woman has remained without detectable HIV for 14 months.
A woman with HIV who received a cord blood stem cell transplant to treat acute myeloid leukemia has had no detectable levels of HIV for 14 months despite cessation of antiretroviral therapy (ART), according to a presentation at today’s Conference on Retroviruses and Opportunistic Infections (CROI). The is the third known case of HIV remission in an individual who received a stem cell transplant. The research was conducted by the International Maternal Pediatric Adolescent AIDS Clinical Trial Network (IMPAACT) P1107 observational study led by Yvonne Bryson, M.D., of the University of California Los Angeles, and Deborah Persaud, M.D., of Johns Hopkins University, Baltimore. The IMPAACT network is funded by the National Institutes of Health.
HIV in Remission After U.S. Woman Receives Haplo-Cord Transplant
FEBRUARY 15, 2022 - By Marie Rosenthal, MS - A middle-aged woman with HIV who received a cord blood stem cell transplant to treat acute myeloid leukemia (AML) has had no detectable levels of HIV for 14 months despite cessation of antiretroviral therapy (ART), according to a presentation at CROI 2022.
Although this is the third known case of HIV remission, there are several “firsts,” according Yvonne J. Bryson, MD, an infectious disease pediatrician at the University of California, Los Angeles, who presented the data. The patient is the first woman with HIV to go into remission. She is the first American, the first person of mixed race, and the first to receive cord blood, which is not typically used for stem cell transplants in adults.
Read more...
Shanghai Public Health Clinical Center Initiated Functional Cure Study of Anti-PD-L1 Antibody ASC22 (Envafolimab) in Combination With Chidamide in HIV-Infected Patients
HANGZHOU, China and SHAOXING, China, Feb. 14, 2022 /PRNewswire/ -- - Ascletis Pharma Inc. (HKEX: 1672) today announces that Shanghai Public Health Clinical Center initiated functional cure study of anti-PD-L1 antibody ASC22 (Envafolimab) in combination with Chidamide in patients infected by human immunodeficiency virus (HIV) with antiviral suppression.
The objective of this study (ClinicalTrials.gov Identifier: NCT05129189) is to evaluate the effect of ASC22 (Envafolimab) combined with Chidamide on the viral reservoirs of latently infected cells in HIV patients. Ascletis BioScience Co., Ltd. and Shenzhen Chipscreen Biosciences Co., Ltd. provide ASC22 and Chidamide, respectively, for the clinical trial.
Heffron named director for Center for AIDS Research
February 14, 2022 - by Adam Pope - Renee Heffron, Ph.D., has been named director for the Center for AIDS Research at the University of Alabama at Birmingham Marnix E. Heersink School of Medicine.
Marc Thompson : Still Here After All These Years
FEBRUARY 14 2022 - By Marie Rosenthal, MS - Marc Thompson, a community leader and co-founder of PrEPster, said that making the Martin Delaney Presentation at CROI 2022 was “special,” not because it was a chance to speak before a distinguished group of HIV physicians, scientists and activists but because it was an opportunity to speak at all.
“It’s special because I never expected to be here, not because of my ability but because of my reality,” Mr. Thompson said. “When I was diagnosed 35 years ago in 1986 at age 17 in the early days of the epidemic, a young Black gay man from a working-class background, the prognosis and life expectancy was a few months and, at most, a few years.
Read more...
Booster vaccine doses protect people with HIV against severe COVID-19
14 February 2022 - Keith Alcorn - Additional and booster vaccine doses have been effective in preventing serious COVID-19 in people with HIV and others with immune dysfunction, a large study from the United States reported this week at the Conference on Retroviruses and Opportunistic Infections (CROI 2022).
Read more...
Zero vertical transmissions from over 5000 pregnant women with undetectable HIV in France
14 February 2022 - Roger Pebody - Data collected since the year 2000 show an HIV transmission rate of 0% among women who were taking HIV treatment at the time of conception, had an undetectable viral load at childbirth and did not breastfeed, the National French Perinatal Cohort reports to the Conference on Retroviruses and Opportunistic Infections (CROI 2022).
Read more...
AHF Marks Int’l Condom Day Today Worldwide!
LOS ANGELES (February 13, 2022) - Events promoting condom use and safer sex are set in more than 37 AHF countries worldwide
As part of the events, AHF is releasing two music videos: ‘I Feel Frisky,’ a burlesque parody of the classic ‘West Side Story’ song, ‘I Feel Pretty,’ and ¡Póntelo! ((Put it On!) a spicy Spanish language song by the Latin Grammy-winning artists Los Rabanes
Happy International Condom Day! Today marks the global holiday that promotes safer sex.
Fungal infections cause more AIDs deaths than tuberculosis, here’s what we can do about it
Feb 13, 2022 - As more and more people are treated for HIV infection, deaths will continue to come down. But the fall is slower than it should be, and the reason for the tardiness of this decrease in deaths is fungal disease.
Even though annual deaths from AIDs are coming down – from a peak of 1.9 million in 2004 to 690,000 in 2020 - that’s still way too many. In 2020, 214,000 people with AIDs died of tuberculosis (TB), though only about 50% were confirmed cases while the rest were uncertain. More people probably die of fungal disease than of TB, both in the context of AIDs and generally.
Read more...
Large number of children living with undetected HIV, experts warn
FEBRUARY 12 2022 - By PAULINE KAIRU - Close to 40 percent of children aged one to 14 years across seven African countries are estimated to be living with undiagnosed HIV.
Health experts say 166,000 children living with HIV in Tanzania, Zambia, Eswatini, Lesotho, Malawi, Namibia and Zimbabwe are not on antiretroviral therapy (ART) and this is indicative of the prevalence of missed HIV diagnosis among children in sub-Saharan Africa.
Read more...
There's a need for blood donations across the country. Advocates say one group is still discriminated from giving
February12, 2022 - CHARLOTTE, N.C. - Jane Monreal, Matthew Ablon (WCNC) - North Carolina leaders say men who have sex with men (MSM) are still unfairly targeted.
Early on in the COVID-19 pandemic, the U.S. Food and Drug Administration (FDA) saw there were new challenges in the blood supply for donations. The FDA took a look at current guidelines on donations and made adjustments. The most notable was a reduction in the deferral period for gay and bisexual men, more commonly referred to by the FDA as men who have sex with men (MSM).
Read more...
Arkansas among seven states with high rural HIV burden
Feb 9, 2022 - by: Jacob Smith - ARKANSAS (KNWA/KFTA) - Arkansas and Oklahoma were recently identified as two of seven states in the U.S. with the highest rural burden of human immunodeficiency virus (HIV).
The seven states identified with the highest rural burden include Alabama, Arkansas, Kentucky, Mississippi, Missouri, Oklahoma, and South Carolina.
Read more...
HIV Incidence Rising Steeply Among People Who Inject Drugs in Tijuana
February 11, 2022 | By Scott LaFee - UC San Diego researchers find that “drug tourism” fueled increased rate of infection, despite extended border closure due to COVID-19 pandemic; findings call for improved prevention measures on both sides of border
At the February 11, 2022 opening of the Conference on Retroviruses and Opportunistic Infection, researchers at University of California San Diego School of Medicine presented data that suggests a new HIV outbreak in Tijuana, Mexico, driven in part by “drug tourism” unabated by the closure of the international border due to the COVID-19 pandemic.
Biktarvy® Demonstrates High Efficacy and Durable Viral Suppression at Five Years, in Treatment-Naïve Adults
February 11, 2022 - FOSTER CITY, Calif.-- (BUSINESS WIRE) -- – Week 240 Results Reinforce the Durability of Biktarvy and Highlight the Potential Role of the Single-Tablet Regimen in Helping to Meet the Long-Term Treatment Needs of a Diverse Group of People Living with HIV –
– Following Five Years of Treatment, Biktarvy Continued to Demonstrate a High Barrier to Resistance with Zero Cases of Treatment Failure Due to Resistance Detected –
Gilead Sciences, Inc. (Nasdaq: GILD) today announced the presentation of cumulative 5-year results from two Phase 3 studies (Study 1489 and Study 1490) of Biktarvy® (bictegravir 50 mg/emtricitabine 200 mg/tenofovir alafenamide 25 mg tablets, B/F/TAF). The new, long-term data further demonstrate the sustained efficacy and safety profile and lack of treatment failure due to resistance in the final resistance analysis population associated with Biktarvy for the treatment of HIV-1 in treatment-naïve adults. The data were presented at the 29th Conference on Retroviruses and Opportunistic Infections (virtual CROI 2022).
Co-discoverer of HIV, Luc Montagnier, has died at the age of 89
GENEVA, 11 February 2022 - The French virologist and co-discoverer of HIV, Luc Montagnier, sadly died this week. He was an expert on retroviruses and a pioneer in HIV science. He founded and directed the Viral Oncology Unit at the Pasteur Institute in France, where he led the team that discovered HIV, research that was first published in the journal Science in 1983.
RESURRECTION: PARTICIPATE IN YOUR OWN SALVATION OR BE COMPLICIT IN YOUR OWN DEMISE
FEBRUARY 10, 2021 - I wrote this book because too many people have died because they were afraid that HIV would kill them. I was inclined to fear the same thing, but my life experiences planted the seeds of hope. I hope that by sharing some of the things that have kept me alive, like a spiritual connection, changing habits, ongoing adventures, faith, hope, and love, others might find some benefit.
Why Jason Kenney’s vile HIV/AIDS comparison struck a nerve
February 9, 2021 - By Mel Woods - OPINION: The Alberta premier compared the experience of unvaccinated people now to those with HIV/AIDS in the 1980s
During a news conference Tuesday, Alberta premier Jason Kenney revealed that when it comes to LGBTQ2S+ issues and HIV/AIDS in particular, he very much is the same man he’s always been.
At the presser announcing a phased end to all COVID-19 restrictions in Alberta (despite Alberta hospitalizations still soaring), Kenney shared sympathy for people opposed to vaccinations or COVID-19 restrictions. And then he took it a step further, and likened the experiences of those who choose not to get vaccinated to the experience of people with HIV/AIDS in the 1980s.
Evolution of the HIV Treatment Landscape
25 FEB 2022 1:00PM – 2:00PM Virtual Event
Speaker: Dr. Sunny Choe, Sr. Medical Scientist, HIV Medical Affairs, Gilead Sciences, Inc
Read more...
Know your status and get an HIV test, says Prince Harry
February 9, 2022 - Prince Harry has urged people to "know your status" and "go and get a test" for HIV.And the Duke of Sussex said he wants to continue his mum's "unfinished" work in removing the stigma around the virus.
His comments come as figures show that for the first time in 10 years, the number of new HIV diagnoses among heterosexuals is higher than for gay and bisexual men in England.
Read more...
Luc Montagnier, Nobel-winning virologist who co-discovered HIV, dies at 89
February 9, 2022 - Soon after reports of a mysterious new disease began circulating in the early 1980s, describing predominantly gay patients with compromised immune systems and rare forms of cancer and pneumonia, Luc Montagnier began working to find the cause.
Read more...
Recharging efforts against HIV/AIDS
February 9, 2022 - About 20 years ago, the Human Immunodeficiency Syndrome, HIV, and Acquired Immune Deficiency Syndrome, AIDS, “enjoyed” pop-star cognisance in our health sector.
It attracted the rave attention currently being given to the Coronavirus Disease, COVID-19.
The HIV, if uncontrolled, advances to its terminal AIDS form.
Read more...
Yes, There is a New Strain of HIV. And No, it’s Not Cause for Alarm.
FEBRUARY 8, 2022 - By Desirée Guerrero - Though the “highly virulent” strain was just identified, it’s actually been around since the ’90s and is easily controlled by HIV treatment.
Scientific researchers in the Netherlands have identified a new strain of HIV that is “highly virulent,” but stress it’s no reason to panic. The findings were published earlier this week in the journal, Science.
Read more...
Gilead to Present Latest Antiviral Research and Development Data at CROI 2022 Addressing Urgent Global Needs
February 8, 2021 - FOSTER CITY, Calif.-- (BUSINESS WIRE) -- – Data Provide New Clinical Insights on Use of Veklury for Treatment of COVID-19 in Patient Populations with Unmet Needs –
– New Findings on Prevention, Treatment and Cure Research Demonstrate Commitment to Scientific Innovation in HIV –
Gilead Sciences, Inc. (Nasdaq: GILD) today announced the upcoming presentation of new data from the company’s HIV and COVID-19 research and development programs at the 29th Conference on Retroviruses and Opportunistic Infections (virtualCROI 2022) taking place from February 12-16. The data reflect Gilead’s enduring dedication to advancing global health through scientific innovation by addressing some of the world’s most challenging viruses. Gilead’s commitment to inclusive research facilitates the discovery and development of person-centered therapeutic options that address the evolving needs of a broad range of individuals.
The social and economic benefits of universal HIV testing and treatment in rural Kenya and Uganda
8 February 2022 - Krishen Samuel - People living with HIV in communities with universal access to HIV testing and treatment were 10% more likely to be employed than those receiving care according to national guidelines, a randomised study has shown. They were also 10% less likely to seek healthcare, 13% less likely to spend money on healthcare and their children were 7% more likely to complete primary school.
Read more...
Positivelove.ca
– A global dating site by and for HIV-positive people
February 8, 2022 – “Be free to be you”
Devan Nambiar grew tired of traditional dating sites that stigmatized against people who were living with HIV. So, he decided to start his own site. Nambiar, a cis-gender gay South Asian-Canadian person living with HIV since 1989, says his goal is to create a dating site strictly for people living with HIV. Millions of people living with HIV are living longer and in relatively good health. And they are looking to date, fall in love, make new friends build and create loving communities. With the science of U=U, Undetectable equals Untransmittable, people living with HIV can plan, and dream of a future of many possibilities without the stigma of HIV.
ECDC publishes considerations for use of face masks in the community
February 8, 2022 – ECDC publishes ‘Considerations for the use of face masks in the community in the context of the SARS-CoV-2 Omicron variant of concern’, a document which updates and complements ‘Using face masks in the community: first update - Effectiveness in reducing transmission of COVID-19’.
Wearing a face mask can help reduce the spread of COVID-19 in the community by reducing the release of respiratory droplets from asymptomatic / pre-symptomatic individuals or those with mild non-specific symptoms. The use of face masks for this purpose may be adopted to reduce the societal impact associated with absence from work or healthcare pressures due to infection, or to protect vulnerable individuals in particular settings.
Heterosexual HIV diagnoses overtake those in gay men for first time in a decade
7 February 2022 - This signals the changing shape of the epidemic as National HIV Testing Week launches.
For the first time in a decade, the number of new HIV diagnoses among heterosexuals is higher than for gay and bisexual men, according to new figures for England from the UK Health Security Agency.
Half of all new HIV diagnoses were in heterosexuals (49%) in England in 2020, compared to 45% in gay and bisexual men.
NBA Legend Earvin “Magic” Johnson, Secretary of AHCA Simone Marstiller and Clear Health Alliance Team up to Promote Awareness, Testing and Treatment for HIV/AIDS
February 7, 2022 – February 7 Marks National Black HIV/AIDS Awareness Day
Clear Health Alliance (CHA) hosted a conversation today among health care providers, community leaders and nonprofit organizations on prevention and care of HIV/AIDS. NBA Legend Earvin “Magic” Johnson was the spotlight of the event at the Jacksonville River City Downtown Hotel, which also featured Secretary Simone Marstiller of the Agency for Health Care Administration (AHCA).
National AIDS Memorial Observes Black History Month with Featured Online Programs Honoring Black Lives Lost to AIDS
SAN FRANCISCO, Feb. 7, 2022 /PRNewswire/ -- Powerful stories are shared through AIDS Memorial Quilt virtual exhibition and stories from the AIDS Memorial Grove that raise awareness about the impact of HIV/AIDS on the Black Community, then and now
The National AIDS Memorial marks Black History Month and National Black HIV/AIDS Awareness Day with featured online programming honoring Black lives touched by AIDS. A specially curated selection of stories is being featured as part of a virtual exhibition of the AIDS Memorial Quilt and engraved names in the National AIDS Memorial Grove.
Identification of fast-spreading HIV variant provides evidence of urgency to halt the pandemic and reach all with testing and treatment
GENEVA, 7 February 2022 - Around 10 million people living with HIV are still not on antiretroviral therapy
Newly published research from the Netherlands has revealed the existence of a more transmissible and damaging variant of HIV. People living with the newly revealed HIV subtype experience double the rate of immune system decline (CD4 count), have higher HIV viral loads (amount of virus in the blood) and are vulnerable to developing AIDS two to three times faster after diagnosis than if they were living with other strains of the virus. The study, led by researchers from the University of Oxford’s Big Data Institute, was the first to discover this highly virulent variant of the subtype-B of HIV. The study also revealed that the variant has been circulating in the Netherlands for years and remains receptive to HIV treatment.
ViiV Healthcare to present new long-term findings from its innovative 2-drug and long-acting HIV medicines portfolio at CROI 2022
London, 7 February 2022 - Data reinforce ViiV Healthcare’s leadership and commitment to developing ground-breaking medicines for HIV treatment and prevention
ViiV Healthcare, the global specialist HIV company majority-owned by GlaxoSmithKline plc (GSK), with Pfizer Inc. (Pfizer) and Shionogi Limited (Shionogi) as shareholders, today announced the presentation of company and investigator sponsored abstracts from its industry-leading HIV treatment and prevention portfolio of approved long-acting medicines and 2-drug regimens (2DRs) at the Conference on Retroviruses and Opportunistic Infections (CROI 2022), being held virtually 12-16 February.
Meet the CTN’s Community Advisory Committee
February 7, 2022 - By: Hannah Branch - The Community Advisory Committee (CAC) is an integral part of the CIHR Canadian HIV Trials Network (CTN). Members include people living with HIV and representatives of organizations fighting the epidemic. The CAC reviews each study submitted to the CTN to ensure that the researchers consider the priorities and concerns of Canadians living with HIV.
The CAC has 11 members; some have been on the committee for many years and others, just a few months, but all make valuable contributions to the CTN.
Let’s meet some of the longer-serving members
Read more...
‘Better education key to tackling stigma of HIV’… Positive Life CEO Jacquie Richardson wants to smash taboo around Aids
February 06 2022 - Aine Toner - A CHARITY dedicated to working for people living with or affected by HIV in Northern Ireland has revealed the stigma that still surrounds it.
Speaking out ahead of Sexual Health Week, which starts on Monday, Positive Life CEO Jacquie Richardson revealed that, while things have moved on since the 1980s, there are still issues in society and even with some working in the healthcare field.
Read more...
Vaccinated Brits won’t have AIDS by the end of February 2022
4 FEBRUARY 2022 - An article shared on social media falsely claims that by the end of February everyone in the UK who has received a Covid-19 vaccine will have Acquired Immunodeficiency Syndrome (AIDS). It also wrongly alleges that “‘vaccine’-related myocarditis” has a 50% five year fatality rate in children.
Potential Alzheimer’s Link to Infectious Diseases Studied
February 4, 2022 - Mark D. Hicar, MD, PhD, associate professor of pediatrics in the Division of Infectious Diseases, has been awarded a $100,000 Microbial Pathogenesis in Alzheimer’s Disease Grant by the Infectious Diseases Society of America (IDSA) Foundation to explore a potential link between infectious diseases and Alzheimer’s disease.
Wistar Scientists Move HIV Vaccine Research Forward by Developing an Immunogen that Produces Tier-2 Antibodies—the Kind That Matter for Combatting HIV
PHILADELPHIA - Feb. 4, 2022 - Nearly four decades after its discovery, HIV has killed 36.3 million people, with no vaccine in sight. However, a new study by researchers at The Wistar Institute, an international biomedical research leader in cancer, immunology, infectious disease, and vaccine development, takes a promising step in the direction of developing an HIV vaccine.
New highly virulent and damaging HIV variant discovered in the Netherlands
4 FEB 2022 - A new HIV variant with higher virulence and more damaging health impacts has been discovered in a study led by the University of Oxford.
As the ongoing coronavirus pandemic has demonstrated, new mutations in viral genetic sequences can have significant impacts on the virus’s transmissibility and the damage it causes. For many years, there have been concerns that this could arise in the HIV-1 virus, which already affects 38 million people worldwide, and has caused 33 million deaths to date (www.unaids.org). This has now been confirmed with the discovery of a new, highly virulent HIV strain in the Netherlands, in an international collaborative study with key contributions from the Dutch HIV Monitoring Foundation and led by researchers from the University of Oxford’s Big Data Institute. The results are published today in Science.
How Will You Show Up In The Fight To End The HIV/AIDS Epidemic?
02/04/2022 - Despite nearly 40 years of advocacy, research, and millions of lives affected, the global community is still fighting the battle against HIV/AIDS.
Read more...
Study Identifies ‘PrEP Reversal’ and Possible Need for New Pharmacy Interventions
Feb. 3, 2022 - Michael Chancley Jr., M.S.W.- One in five patients who are newly prescribed oral PrEP medication for HIV prevention are delayed filling their prescription by at least two weeks, according to a study titled, “Assessing Gaps in HIV Pre-Exposure Prophylaxis (PrEP) Initiation and Retention Using Pharmacy Claims Data,” led by Lorraine Dean, Sc.D., Dr. Amy S. Nunn, Sc.D., MS and other researchers at Johns Hopkins and Brown universities.
Read more...
Tracking the cells that host HIV
FEBRUARY 3, 2022 - Two phases of viral decline, now understood more clearly
New research sheds light on the lifespans and location of the cells that are responsible for producing HIV, preventing its eradication. Understanding the cells’ dynamics may help scientists develop new ways to reduce their number with the ultimate goal of curing HIV infection.
FACT SHEET: The Biden Administration's Commitment to Global Health
February 3, 2022 - The United States Government is proud to be the largest donor for global health. As we work to end the COVID-19 pandemic, we remain committed to strengthening health systems and institutions; advancing global health security; combatting HIV/AIDS, malaria, and tuberculosis; advancing sexual and reproductive health and rights, and maternal, neonatal, and child health; closing gaps in nutrition and non-communicable diseases; and accelerating efforts towards universal health coverage and the Sustainable Development Agenda. In Fiscal Year (FY) 2021, the United States appropriated over $9 billion in global health programs, in addition to almost $16 billion in emergency supplemental funding for COVID-19.
Reginald Smith on Heterosexual Black Men, HIV, and Healing
FEBRUARY 2, 2022 - Mr. Reginald (Reggie) Smith serves as Director of the Reginald & Dionne Smith Foundation, which “works to improve total wellness for families affected by HIV, Hepatitis, and substance use disorders through education, advocacy, resources, and links to care”. His latest book, “Resurrection” – Participate in Your own Salvation or be Complicit in Your own Demise, is available on his website, as well as information on joining his community.
Read more...
NEW ANTI-HIV ANTIBODY FUNCTION DISCOVERED: TETHERING OF VIRAL PARTICLES AT THE SURFACE OF CELLS
Feb 2, 2022 - Teams at the Institut Pasteur, CNRS, Vaccine Research Institute (VRI) and Université de Paris have discovered a new function of anti-HIV-1 antibodies by applying cutting-edge microscopy techniques to in vitro viral cultures. The scientists found that certain antibodies already known for effectively targeting HIV-1 envelope (Env) protein can prevent infected cells from releasing viral particles, thus halting viral spread. The antibodies are Y-shaped, enabling them to attach themselves between the infected cell and viral particles or directly between viral particles. This chain composed of antibodies and viral particles prevents viral spread. These findings demonstrate that these powerful antibodies exhibit different antiviral activities in addition to neutralization. The study is published in the February 2, 2022 issue of Nature Communications.
Quebec researcher finds similarity in COVID-19 and AIDS
Feb 2, 2022 - "This may have an impact on an individual's immunity," says Jérôme Estaquier, a researcher at the Université of Laval. He and a team discovered similarities in COVID-19 and AIDS, which may help with the death rate of COVID-19. Felisha Adam reports.
GSK announces settlement between ViiV Healthcare and Gilead Sciences, Inc. resolving litigation relating to Biktarvy and ViiV’s dolutegravir patents and entry into a patent licence agreement
01 February 2022 - GlaxoSmithKline plc (LSE/NYSE: GSK) today announced that ViiV Healthcare, the global specialist HIV company majority-owned by GSK, with Pfizer Inc. and Shionogi & Co. Limited (Shionogi) as shareholders, has agreed to settle the global patent infringement litigation between GSK, Shionogi and Gilead Sciences, Inc. (Gilead) concerning ViiV Healthcare’s patents relating to dolutegravir, an antiretroviral medication used, together with other medicines, to treat human immunodeficiency virus (HIV).
Hepatitis C treatment and cure targets for people living with HIV still not being met in Europe
1 February 2022 - Alain Volny-Anne - While over 90% of people living with HIV in Europe have been tested for hepatitis C, diagnosis remains suboptimal in the east of the continent. In three of five European regions, fewer than 80% of people co-infected with HIV and hepatitis C have received hepatitis treatment and the proportion who have been cured does not exceed 80% in any region. The study published in the March issue of AIDS also shows that there are significant differences between countries.
Read more...
Study supports pricing long-acting injectable cabotegravir to compete with generic oral HIV PrEP
February 1, 2021 - BOSTON - The value of a new, highly effective long-acting injectable HIV prevention medication, recently approved by the Food and Drug Administration, will hinge on how it is priced, according to a study led by researchers at Massachusetts General Hospital (MGH) published in Annals of Internal Medicine. The study authors demonstrate that the superiority of long-acting injectable cabotegravir (CAB-LA) to prevent HIV over oral alternatives among high-risk men who have sex with men (MSM) and transgender women (TGW) in the United States would not justify a large price difference for the new medication.
ViiV Healthcare announces US FDA approval of Cabenuva (cabotegravir, rilpivirine) for use every two months, expanding the label of the first and only complete long-acting HIV treatment
London, 1 February 2022 - Cabenuva is now approved for administration as few as six times a year for virologically suppressed adults living with HIV without prior treatment failure or resistance to cabotegravir or rilpivirine
ViiV Healthcare, the global specialist HIV company majority-owned by GlaxoSmithKline plc (GSK), with Pfizer Inc. (Pfizer) and Shionogi Limited (Shionogi) as shareholders, today announced that the US Food and Drug Administration (FDA) approved Cabenuva (cabotegravir, rilpivirine) for every-two-month dosing for the treatment of HIV-1 in virologically suppressed adults (HIV-1 RNA less than 50 copies per millilitre [c/ml]) on a stable regimen, with no history of treatment failure, and with no known or suspected resistance to either cabotegravir or rilpivirine.
|
